ALX-0600, a glucagon-like peptide-2 (GLP-2) analog, enhances intestinal structure and function in patients with short bowel syndrome (SBS)

被引：0
|
作者：
Tappenden, KA
Bartholome, AL
Demchyshyn, L
Lopansri, J
Sanguinetti, E
Blosch, C
Lechago, J
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1250
引用
收藏
页码：A192 / A192
页数：1
相关论文
共 50 条
  • [31] Glucagon-like peptide-2 enhances intestinal function following massive small bowel resection.
    Kato, Y
    Alavi, K
    Yu, D
    Schwartz, MZ
    GASTROENTEROLOGY, 1998, 114 (04) : A1152 - A1152
  • [32] The Combination of Dietary Lipids and a Sweetener Creates a Synergy on the Intestinal Glucagon-Like Peptide-2(GLP-2) Secretion
    Sato, Shingo
    Hokari, Ryota
    Hozumi, Hideaki
    Ueda, Toshihide
    Higashiyama, Masaaki
    Okada, Yoshikiyo
    Kurihara, Chie
    Komoto, Shunsuke
    Watanabe, Chikako
    Nakamura, Mitsuyasu
    Tomita, Kengo
    Kawaguchi, Atsushi
    Nagao, Shigeaki
    Miura, Soichiro
    GASTROENTEROLOGY, 2011, 140 (05) : S322 - S323
  • [33] Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome
    Yazbeck, Roger
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (06) : 798 - 809
  • [34] An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults
    Zhu, Changzhen
    Li, Yuanxin
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (03)
  • [35] A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients
    Naimi, R. M.
    Madsen, K. B.
    Askov-Hansen, C.
    Brandt, C. F.
    Hartmann, B.
    Holst, J. J.
    Mortensen, P. B.
    Jeppesen, P. B.
    REGULATORY PEPTIDES, 2013, 184 : 47 - 53
  • [36] GLEPAGLUTIDE, A GLUCAGON-LIKE PEPTIDE-2 ANALOG, AMELIORATES ACCELERATED GASTROINTESTINAL TRANSIT TIME IN PATIENTS WITH SHORT BOWEL SYNDROME
    Hvistendahl, Mark
    Naimi, Rahim M.
    Enevoldsen, Lotte H.
    Madsen, Jan L.
    Fuglsang, Stefan
    Hansen, Mark B.
    Jeppesen, Palle B.
    GASTROENTEROLOGY, 2018, 154 (06) : S655 - S655
  • [37] Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study
    Madsen, K. B.
    Askov-Hansen, C.
    Naimi, R. M.
    Brandt, C. F.
    Hartmann, B.
    Holst, J. J.
    Mortensen, P. B.
    Jeppesen, P. B.
    REGULATORY PEPTIDES, 2013, 184 : 30 - 39
  • [38] Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome
    Martin, GR
    Wallace, LE
    Sigalet, DL
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 286 (06): : G964 - G972
  • [39] Effect of Glucagon-like Peptide-2 (GLP-2) on Diurnal SGLT1 Expression
    Anthony P. Ramsanahie
    Urs V. Berger
    Michael J. Zinner
    Edward E. Whang
    David B. Rhoads
    Stanley W. Ashley
    Digestive Diseases and Sciences, 2004, 49 : 1731 - 1737
  • [40] Effect of glucagon-like peptide-2 (GLP-2) on diurnal SGLT1 expression
    Ramsanahie, AP
    Berger, UV
    Zinner, MJ
    Whang, EE
    Rhoads, DB
    Ashley, SW
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (11-12) : 1731 - 1737
12345